Spinal Cord Stimulation Market Size

Spinal Cord Stimulation Market size was valued at USD 3.25 Billion in 2023 and is poised to grow from USD 3.5 Billion in 2024 to USD 6.27 Billion by 2032, growing at a CAGR of 7.58% during the forecast period (2025-2032).

The spinal cord stimulator (SCS), also called the dorsal column stimulator is a neuromodulation tool that is implanted in the body to treat chronic pain. By emitting electric signals that block pain signals, the device stops the brain from being able to perceive pain. The purpose of having a stimulator is to manage the pain related to spinal cord, back, arms, and legs. Medically, it is used in treating chronic pain conditions that fail to respond to medication and other massage therapies. Thus, the SCS therapy follows neurostimulation that enables electrical impulses to relieve chronic pain in the joints.

Due to technical improvement, the emergence of legislative guidelines for SCS operations, and the quick uptake of minimally invasive therapies, SCS is drawing more attention globally. The market is booming at present and is expected to create move avenues in the forthcoming years based on high adoption of neurostimulation and a high prevalence of chronic pain in the population owing to the pursuit of sedentary lifestyle.

US Spinal Cord Stimulation Market is poised to grow at a sustainable CAGR for the next forecast year.